A link to the Copyright Permissions Request Form appears on the right side of the page. ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines WRITING COMMITTEE MEMBERS Paul K. Whelton, MB, MD, MSc, FAHA, Chair; Robert M. Carey, MD, FAHA, Vice Chair; Wilbert S. Aronow, MD, FACC, FAHA*; Donald E. Casey, Jr, MD, MPH, MBA, FAHA ; Karen J. Collins, MBA ; Cheryl Dennison Himmelfarb, RN, ANP, PhD, FAHA ; Sondra M. DePalma, MHS, PA-C, CLS, AACC ; Samuel Gidding, MD, FAHA ; Kenneth A. Jamerson, MD#; Daniel W. Jones, MD, FAHA ; Eric J. MacLaughlin, PharmD**; Paul Muntner, PhD, FAHA ; Bruce Ovbiagele, MD, MSc, MAS, MBA, FAHA ; Sidney C. Smith, Jr, MD, MACC, FAHA ; Crystal C. Spencer, JD ; Randall S. Stafford, MD, PhD ; Sandra J. Taler, MD, FAHA ; Randal J. Thomas, MD, MS, FACC, FAHA ; Kim A. Williams, Sr, MD, MACC, FAHA ; Jeff D. Williamson, MD, MHS ; Jackson T. Wright, Jr, MD, PhD, FAHA## Clinical Practice Guideline 2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYP.0000000000000065 Table of Contents Preamble e15 1.1. Methodology and Evidence Review e16 1.2. Organization of the Writing Committee e17 1.3. Document Review and Approval e18 1.4. Scope of the Guideline e18 1.5. Abbreviations and Acronyms e18 2. BP and CVD Risk e19 2.4. Coexistence of Hypertension and Related Chronic Conditions e20 3. Classification of BP e21 3.1. Definition of High BP e21 3.2. Lifetime Risk of Hypertension e22 3.3. Prevalence of High BP e22 3.4. Awareness, Treatment, and Control e22 4. Measurement of BP e23 4.1. 